Using ketone supplements to improve heart health in women with PCOS
Official title: Exogenous Ketone Supplementation to Improve Cardiovascular Disease Risk Factors in Females with Polycystic Ovary Syndrome
Run by McGill University · NCT06155708 · Data updated 2026-11-12
This study tests if taking ketone supplements can help improve heart health in women aged 18 to 40 who have polycystic ovary syndrome (PCOS).
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | McGill University Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Status | Recruiting |
| Started | January 20, 2025 |
| Main results expected | June 2027 |
| Study ends | December 2027 |
| Registry record updated | January 22, 2025 |
| Trial ID | NCT06155708 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are females aged 18 to 40 who have been diagnosed with polycystic ovary syndrome.
✕Probably not a fit
Patients with overt cardiometabolic diseases, current pregnancy, or those on certain medications may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of exogenous ketone monoester supplementation on cardiovascular health in females diagnosed with polycystic ovary syndrome (PCOS). PCOS is a common condition that can lead to serious cardiovascular issues due to insulin resistance and elevated blood pressure. The trial aims to determine whether ketone supplementation can improve markers of cardiovascular health in this population. Participants will be females aged 18 to 40 with a confirmed diagnosis of PCOS, and they will receive either ketone supplements or water as a control.
Why it matters
Potential benefit: If successful, this study could provide a novel dietary intervention to improve cardiovascular health in women with PCOS.
How similar studies have gone: While the use of ketone supplementation has shown promise in other populations, this specific application in PCOS is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All female participants will report female sex assigned at birth * All participants will be aged 18 to 40 * PCOS diagnosis Exclusion Criteria: * Current smokers or a prolonged history of smoking * Presence or history of overt cardiometabolic disease (e.g., stage 2 hypertension, diabetes, heart disease), neurologic disease, or endocrinopathy (with the exception of PCOS) * Current pregnancy or currently breastfeeding * Current use of medications which may affect our outcomes of interest (e.g., anti-hypertensives, anti-androgens, metformin)
Where it's running
-
Cardiovascular Health and Autonomic Research Laboratory
Montreal, Quebec, Canada Recruiting
Study contacts
- Principal investigator: Charlotte Usselman, Ph.D — McGill University
- Study coordinator: Charlotte Usselman, Ph.D
- Email: charlotte.usselman@mcgill.ca
- Phone: 5143962140
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PMOS and Sleep Apnea: A Pilot Look at Mitochondrial Function
In women with PMOS, this pilot study tests whether sleep apnea treatment with CPAP improves mitochondrial function in leg muscle tissue.
-
PCOS and Brain Health
This study tests how PCOS may affect brain blood flow, brain structure, and thinking skills in reproductive-age people with and without PCOS.
-
Adding cabergoline to letrozole for ovulation in PCOS
This study will see if adding cabergoline to letrozole helps women with PCOS ovulate more often.
-
Investigating cardiovascular markers in women with PCOS during glucose testing
This study is testing how glucose testing affects heart health markers in women with PCOS and whether different treatments can improve those markers over six months.
-
PIMS versus PGT-A for embryo selection in women with PCOS
This test will see if selecting embryos with Pre-implantation Methylation Screening (PIMS) instead of PGT-A plus standard morphology leads to higher cumulative live birth rates and lower early pregnancy loss for women with PCOS undergoing IVF/ICSI.
-
Comparing adipokine levels in women with and without PCOS
This study is trying to see how levels of certain fat-related proteins differ in women with polycystic ovary syndrome (PCOS), both with and without insulin resistance, compared to women without PCOS.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.